ADIAL PHARMACEUTICALS, INC. ADIL Cash Flow

Mar'20	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss
0	-7,802	-14,277	-13,935	-11,631	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation
0	1,433	4,516	5,583	5,368	0	0	0
Non-cash warrant modification expense
-	0	0	0	-	-	-	-
Amortization of intangible assets
0	0	0	0	0	0	0	0
Amortization of debt discounts
-	-	-	-	352	0	0	0
Loss on debt extinguishments
-	-	-	-	-3,484	0	0	0
Changes in operating assets and liabilities:
Prepaid research and development expenses
0	0	0	0	-	-	-	-
Prepaid expenses and other current assets
0	0	0	0	-	-	-	-
Accounts payable
-	-	-	-	-190	0	0	0
Accrued expenses
0	-	-	0	-	-	-	-
Accounts payable
0	-	-	0	-	-	-	-
Net cash used in operating activities
0	-5,689	-4,956	-4,005	-2,498	0	0	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from sale of common stock and warrants
-	0	0	0	-	-	-	-
Proceeds from Senior Secured Notes, including related party
-	-	-	-	410	0	0	0
Repayment of Senior Secured Bridge Note
-	-	-	-	150	0	0	0
Proceeds from warrant exercise
-	0	0	0	-	-	-	-
Net cash provided by financing activities
-	9,402	15,060	15,345	6,349	0	0	0
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
0	3,712	10,103	11,340	3,850	0	0	0
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Previously accrued expenses paid in equity
0	-	-	-	-	-	-	-
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Senior note issued for payment to Senior Bridge Note
-	-	-	-	-	-	-	0
Senior note issued for Subscription Receivable
-	-	-	-	-	-	-	0
Exchange of Subordinated notes in the amount of $115,639 for Senior secured notes
-	-	-	-	100	0	0	0